Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings per share (EPS) is -3.85.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -1.18.
EARNINGS PER SHARE (EPS)
-3.85
EARNINGS PER SHARE (EPS) AVG TTM
N/A
EARNINGS PER SHARE (EPS) AVG 3Y
N/A
EARNINGS PER SHARE (EPS) AVG 5Y
N/A
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Atrium Therapeutics, Inc.
Market Cap
$136.41M
Earnings Per Share (EPS)
-3.85
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$136.88M
Earnings Per Share (EPS)
-0.04
TTM Avg
-0.09
3Y Avg
-0.17
5Y Avg
-0.13
Market Cap
$138.23M
Earnings Per Share (EPS)
-1.11
TTM Avg
-1.59
3Y Avg
-2.87
5Y Avg
-3.93
Market Cap
$134.88M
Earnings Per Share (EPS)
0.45
TTM Avg
-0.23
3Y Avg
-0.84
5Y Avg
-0.86
Market Cap
$133.72M
Earnings Per Share (EPS)
-0.51
TTM Avg
-0.38
3Y Avg
-0.76
5Y Avg
-1.59
Market Cap
$132.98M
Earnings Per Share (EPS)
-0.18
TTM Avg
-0.17
3Y Avg
-0.17
5Y Avg
-0.09
Market Cap
$132.64M
Earnings Per Share (EPS)
-3.68
TTM Avg
-1.85
3Y Avg
-2.09
5Y Avg
-2.42
Market Cap
$140.49M
Earnings Per Share (EPS)
-1.04
TTM Avg
-1.66
3Y Avg
-1.77
5Y Avg
-1.60
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Atrium Therapeutics, Inc. (RNA) | $136.41M | -3.85 | N/A | N/A | N/A |
| KORU Medical Systems, Inc. (KRMD)vs › | $136.88M | -0.04 | -0.09 | -0.17 | -0.13 |
| Freenome, Inc. (FRNM)vs › | $135.08M | N/A | N/A | N/A | N/A |
| Alpha Cognition Inc (ACOG)vs › | $138.23M | -1.11 | -1.59 | -2.87 | -3.93 |
| Organigram Global Inc. (OGI)vs › | $134.88M | 0.45 | -0.23 | -0.84 | -0.86 |
| LifeMD, Inc. (LFMD)vs › | $133.72M | -0.51 | -0.38 | -0.76 | -1.59 |
| AirSculpt Technologies, Inc. (AIRS)vs › | $132.98M | -0.18 | -0.17 | -0.17 | -0.09 |
| Health Catalyst, Inc. (HCAT)vs › | $132.64M | -3.68 | -1.85 | -2.09 | -2.42 |
| Immuneering Corporation (IMRX)vs › | $140.49M | -1.04 | -1.66 | -1.77 | -1.60 |
| Sutro Biopharma, Inc. (STRO)vs › | $141.00M | -17.42 | -26.05 | -23.35 | -21.03 |
Trailing EPS (TTM)
$-3.85
Forward EPS (Est.)
$-4.57
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -4.48 |
